Related Experiment Video

Updated: May 6, 2026

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

22.8K

Dmp1α inhibits HER2/neu-induced mammary tumorigenesis

Elizabeth A Fry1, Pankaj Taneja, Dejan Maglic

  • 1Department of Pathology, Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States of America ; Department of Cancer Biology, Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States of America.

Plos One
|November 9, 2013
PubMed

Insights

Dmp1 plays a crucial role in preventing breast cancer by regulating the HER2 pathway. Restoring Dmp1α expression may offer a new therapeutic strategy for breast cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Dmp1 acts as a tumor suppressor by inhibiting hyperproliferative signals.
  • The HER2 pathway is frequently activated in breast cancer, driving oncogenesis.
  • Understanding Dmp1's role in HER2-driven cancer is crucial for developing new therapies.

Purpose of the Study:

  • To investigate the role of Dmp1 in preventing HER2/neu-driven breast cancer.
  • To establish and characterize transgenic mouse models expressing Dmp1α.

Main Methods:

  • Generation of Flag-Dmp1α transgenic mice (MDTG) using the MMTV promoter.
  • Analysis of mammary gland development, senescence markers (Arf, Ink4a, p53, p21), and proliferation marker (Ki-67).
  • Evaluation of tumor development, weight, and transgene expression in MDTG;neu mice.

Main Results:

  • MDTG mice showed impaired mammary gland development and reduced milk production.
  • MDTG mice exhibited markers of senescence and aging, with low proliferation.
  • MDTG;neu mice displayed significantly delayed tumor development and reduced tumor weight, with Dmp1α expression inversely correlated with Ki-67.
  • Transgene loss and protein downregulation were observed in MDTG;neu tumors.

Conclusions:

  • Dmp1 plays a critical role in preventing mammary tumorigenesis by quenching HER2-driven signals.
  • Transgenic Dmp1α expression delays tumor growth in vivo.
  • Restoring Dmp1α expression presents a potential therapeutic strategy for breast cancer.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

13.1K
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.2K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K